Respiratory Trials·org

Pulmonary embolism · Thromboprophylaxis in critical illness

PREVENT-IPC randomised trial

Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis

PREVENT-IPC trial design and results
Design Multicentre randomised controlled trial
Treatment Intermittent pneumatic compression added to pharmacological thromboprophylaxis
Control Pharmacological thromboprophylaxis alone
Population 2003 critically ill patients already receiving pharmacological thromboprophylaxis
Follow-up ICU stay to 28 days
Primary endpoint Incident proximal lower-limb deep-vein thrombosis
Result Compression was applied for a median of 22 hours daily (IQR 21 to 23) over a median of 7 days. Adding it did not significantly reduce the incidence of proximal lower-limb deep-vein thrombosis compared with pharmacological prophylaxis alone.
Secondary endpoints Any deep-vein thrombosis, pulmonary embolism, mortality

Among critically ill patients who were receiving pharmacologic thromboprophylaxis, adjunctive intermittent pneumatic compression did not result in a significantly lower incidence of proximal lower-limb deep-vein thrombosis than pharmacologic thromboprophylaxis alone.

The trial authors, in the published abstract

How it has aged

Well-delivered — 22 hours a day for a week — which is what makes the negative result convincing rather than a failure of adherence. Mechanical prophylaxis retains a role where anticoagulation is contraindicated; adding it on top is simply cost and nursing time.

Publications

Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis

Arabi YM, Al-Hameed F, Burns KEA, et al. Adjunctive Intermittent Pneumatic Compression for Venous Thromboprophylaxis. N Engl J Med 2019 Apr 4;380(14):1305-1315.

  • No reduction in proximal deep-vein thrombosis
  • Compression delivered for a median 22 hours per day